CLINICAL_TRIALS
trial_result
· 2014-10-15
Clinical Trial Update: A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy [Phase 4]
Summary
Phase 4 study evaluating the persistence of response after long-term omalizumab therapy in allergic asthma, comparing continued treatment with stopping.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Allergic Asthma | Phase 4 | Status: COMPLETED | Results posted: 2014-10-15